225
Views
6
CrossRef citations to date
0
Altmetric
Research Article

The Relationship between Antidepressant Use and Smoking Cessation in Pregnant Women in Treatment for Substance Abuse

, M.D., , M.D., , M.S.W., , M.D. & , Ph.D.
Pages 46-51 | Published online: 08 Feb 2010

REFERENCES

  • U.S. Department of Health and Human Services. The health consequences of smoking: A report of the surgeon general. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General, 2004.
  • U.S. Department of Health and Human Services. Women and smoking: A report of the surgeon general. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General, 2001.
  • Hoffman S, Hatch MC. Depressive symptomatology during pregnancy: Evidence for an association with decreased fetal growth in pregnancies of lower social class women. Health Psychol 2000; 19:535–543.
  • Haug NA, Svikis DS, Diclemente C. Motivational enhancement therapy for nicotine dependence in methadone-maintained pregnant women. Psychol Addict Behav 2004; 18:289–292.
  • Kuczkowski KM. The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol. 2007; 19:578–585.
  • Solomon L, Quinn V. Spontaneous quitting: Self-initiated smoking cessation in early pregnancy. Nicotine Tob Res 2004; 6(Suppl 2):S203–216.
  • Shoptaw S, Rotheram-Fuller E, Yang X, et al. Smoking cessation in methadone maintenance. Addiction 2002; 97:1317–1328; discussion 1325.
  • Kessler RC, McGonagle KA, Nelson CB, Hughes M, Swartz M, Blazer DG. Sex and depression in the national comorbidity survey. II: Cohort effects. J Affect Disord 1994; 30:15–26.
  • Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: Systematic review. Obstet Gynecol 2004; 103:698–709.
  • Martin PR, Arria AM, Fischer G, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Selby P, Jones HE. Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict 2009; 18:148–156.
  • Blalock JA, Fouladi RT, Wetter DW, Cinciripini PM. Depression in pregnant women seeking smoking cessation treatment. Addict Behav 2005; 30:1195–1209.
  • Henry AL, Beach AJ, Stowe ZN, Newport DJ. The fetus and maternal depression: Implications for antenatal treatment guidelines. Clin Obstet Gynecol. 2004; 47:535–546.
  • Wisner KL, Sit DK, Hanusa BH, et al. Major depression and antidepressant treatment: Impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009; 166:557–566.
  • ACOG Committee on Practice Bulletins–Obstetrics. ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, april 2008 (replaces practice bulletin number 87, november 2007). use of psychiatric medications during pregnancy and lactation. Obstet Gynecol. 2008; 111;1001–1020.
  • Calderon-Margalit R, Qiu C, Ornoy A, Siscovick DS, Williams MA. Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. Am J Obstet Gynecol. 2009.
  • Ramos E, Oraichi D, Rey E, Blais L, Berard A. Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG. 2007; 114:1055–1064.
  • Marchetti F, Romero M, Bonati M, Tognoni G. Use of psychotropic drugs during pregnancy. A report of the international co-operative drug use in pregnancy (DUP) study. collaborative group on drug use in pregnancy (CGDUP). Eur J Clin Pharmacol. 1993; 45:495–501.
  • Cohen LS, Nonacs R, Viguera AC, Reminick A. Diagnosis and treatment of depression during pregnancy. CNS Spectr. 2004; 9:209–216.
  • Howland RH. Categorizing the safety of medications during pregnancy and lactation. J Psychosoc Nurs Ment Health Serv. 2009; 47:17–20.
  • Einarson A, Choi J, Einarson TR, Koren G. Incidence of major malformations in infants following antidepressant exposure in pregnancy: Results of a large prospective cohort study. Can J Psychiatry. 2009; 54:242–246.
  • Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: A report from the american psychiatric association and the american college of obstetricians and gynecologists. Gen Hosp Psychiatry. 2009; 31:403–413.
  • Cole JA, Modell JG, Haight BR, Cosmatos IS, Stoler JM, Walker AM. Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf. 2007; 16:474–484.
  • Way CM. Safety of newer antidepressants in pregnancy. Pharmacotherapy. 2007; 27:546–552.
  • Chun-Fai-Chan B, Koren G, Fayez I, et al. Pregnancy outcome of women exposed to bupropion during pregnancy: A prospective comparative study. Am J Obstet Gynecol. 2005; 192:932–936.
  • Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of major malformations: A meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf. 2005; 14:823–827.
  • Slotkin TA. If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents? Neurotoxicol Teratol. 2008; 30:1–19.
  • U.S. Preventive Services Task Force. Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. preventive services task force reaffirmation recommendation statement. Ann Intern Med. 2009; 150:551– 555.
  • Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. public health service report. Am J Prev Med. 2008; 35:158–176.
  • Wilkes S. Bupropion. Drugs Today (Barc). 2006; 42:671–681.
  • Crawford JT, Tolosa JE, Goldenberg RL. Smoking cessation in pregnancy: Why, how, and what next. Clin Obstet Gynecol. 2008; 51:419–435.
  • Chan B, Einarson A, Koren G. Effectiveness of bupropion for smoking cessation during pregnancy. J Addict Dis. 2005; 24:19–23.
  • Rigotti NA, Park ER, Chang Y, Regan S. Smoking cessation medication use among pregnant and postpartum smokers. Obstet Gynecol. 2008; 111:348–355.
  • Jansson LM, Svikis DS, Velez M, Fitzgerald E, Jones HE. The impact of managed care on drug-dependent pregnant and postpartum women and their children. Subst Use Misuse. 2007; 42:961–974.
  • U.S. Federal Drug Administration. Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm169986.htm. Acc-essed October/08, 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.